Andreas Yiangou

Andreas Yiangou is an Academic Clinical Lecturer in Neurology, actively contributing to research on idiopathic intracranial hypertension (IIH) and its associated mechanisms. His work spans clinical trials, metabolomics, and neuroimaging, with a focus on drug efficacy, weight management, and non-invasive diagnostic tools.

• 2025: Co-led a clinical trial on ICP-lowering drugs in IIH (Headache journal).
• 2025: Developed MRI-based non-invasive intracranial compliance assessment (Eye journal).
• 2023: Published a comprehensive review on IIH disease mechanisms (Nature Reviews Neurology).
• 2022: Demonstrated weight loss correlation with intracranial pressure reduction (Neurology).
• 2022: Identified metabolic dysregulation in IIH using metabolomics (Journal of Proteome Research).

His research integrates neurology, metabolic science, and surgical outcomes, supported by funding from the US Army Medical Research Acquisition Activity and the Association of British Neurologists. In 2021, he received the Clinical Research Training Fellowship, underscoring his expertise in IIH therapeutics and clinical investigation.